Adalimumab-adbm Kit
Product Images NDC 82009-148
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 34 technical images submitted to the FDA as part of the official labeling for Adalimumab-adbm (NDC 82009-148). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Quallent Pharmaceuticals Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2 (Adalimumabqt 02)
Figure 3 (Study UV I)
Figure 3 (Study UV II)
Image (Adalimumabqt 05)
Step 1 (Adalimumabqt 06)
Step 2 (Adalimumabqt 07)
Step 3 (Adalimumabqt 08)
Step 4 (Adalimumabqt 09)
Step 5 (Adalimumabqt 10)
Step 6 (Adalimumabqt 11)
Step 7 (Adalimumabqt 12)
Step 8 (Adalimumabqt 13)
Step 9 (Adalimumabqt 14)
Step 10 (Adalimumabqt 15)
Step 10 (Adalimumabqt 16)
Step 11 (Adalimumabqt 17)
Image (Adalimumabqt 18)
Step 1 (Adalimumabqt 19)
Step 2 (Adalimumabqt 20)
Step 3 (Adalimumabqt 21)
Step 4 (Adalimumabqt 22)
Step 5 (Adalimumabqt 23)
Step 6 (Adalimumabqt 24)
Step 7 (Adalimumabqt 25)
Step 8 (Adalimumabqt 26)
Step 9 (Adalimumabqt 27)
Step 10 (Adalimumabqt 28)
Step 10 (Adalimumabqt 29)
Step 11 (Adalimumabqt 30)
Principal Display Panel (Kit Carton)
This text appears to be a label or instructions for a medical product, likely related to a medication called Adalimumab-adbm PEN. It contains information about dosage, expiration date, and proper usage guidelines for subcutaneous administration. The product seems to come in single-dose prefilled pens and contains adalimumab. It is important to note that specific details about the medication's administration and storage are also mentioned.*
Principal Display Panel (Kit Carton)
This text refers to the instructions and details of a medication called Adalimumab-adbm PEN Injection, which is intended for subcutaneous use. The medication comes in the form of two single-dose prefilled pens, each containing 40 mg of the solution. It is essential not to use this medication beyond the expiration date mentioned.*
Principal Display Panel (Kit Carton)
Principal Display Panel (Kit Carton)
This is a description of a medication called Adalimumab-adbm, which is an injection containing 40 mg/0.8 mL for subcutaneous use. The medication comes in 2 single-dose prefilled syringes and should not be used beyond the expiration date. It is important for each patient to receive the enclosed medication guide. The packaging includes natural rubber and dry syringes. The text provides detailed instructions and numbers related to dosage and administration.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.